Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: enfortumab-vedotin therapy ×

enfortumab-vedotin therapy

This treatment is selected. Its supporting articles are shown below.

enfortumab-vedotin therapy1

Articles mentioning enfortumab-vedotin therapy

1 articles · page 1 of 1

Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma

bmjcr · abstract · 2026-02-12 · 1 matching annotations

81.8%

enfortumab-vedotin therapy urothelial carcinoma neuroendocrine carcinoma Neuroendocrine carcinomas novel interventions

…roendocrine carcinoma, potentially as a resistance mechanism to enfortumab-vedotin therapy, as the dynamic nature of tumour cells may contribute to resist…

Browse treatments

enfortumab-vedotin therapy

Articles mentioning enfortumab-vedotin therapy

Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma